Article

Diabetes, Obesity Boost Infection Risk in Hip and Knee Replacements for Osteoarthritis

The risk of periprosthetic joint infection after primary hip and knee replacements for osteoarthritis is increased by diabetes mellitus. It also is increased by morbid obesity.

The risk of periprosthetic joint infection after primary hip and knee replacements for osteoarthritis (OA) is increased by diabetes mellitus (DM). It also is increased by morbid obesity.

Jmsen and coworkers analyzed the 1-year incidence of periprosthetic joint infections in a series of 7181 primary hip and knee replacements performed to manage OA. Data about periprosthetic joint infection were collected from the hospital infection register and were based on prospective, active surveillance.

The periprosthetic joint infection rate increased from 0.37% in patients with a normal body mass index to 4.66% in the morbidly obese group. DM more than doubled the periprosthetic joint infection risk independent of obesity. The infection rate was highest in morbidly obese patients with DM. In patients who did not have a diagnosis of DM at the time of the surgery, there was a trend toward a higher infection rate in association with a preoperative glucose level of 6.9 mmol/L or higher compared with lower than 6.9 mmol/L. The infection rate was 1.15% in the former group compared with 0.28% in the latter.

The authors suggested that clinicians carefully weigh the benefits of joint replacement against the incidence of postoperative infection, especially in morbidly obese patients.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.